319 related articles for article (PubMed ID: 28760504)
1. Protection against RAGE-mediated neuronal cell death by sRAGE-secreting human mesenchymal stem cells in 5xFAD transgenic mouse model.
Son M; Oh S; Park H; Ahn H; Choi J; Kim H; Lee HS; Lee S; Park HJ; Kim SU; Lee B; Byun K
Brain Behav Immun; 2017 Nov; 66():347-358. PubMed ID: 28760504
[TBL] [Abstract][Full Text] [Related]
2. sRAGE prolonged stem cell survival and suppressed RAGE-related inflammatory cell and T lymphocyte accumulations in an Alzheimer's disease model.
Oh S; Son M; Choi J; Lee S; Byun K
Biochem Biophys Res Commun; 2018 Jan; 495(1):807-813. PubMed ID: 29127006
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of soluble RAGE in mesenchymal stem cells enhances their immunoregulatory potential for cellular therapy in autoimmune arthritis.
Park MJ; Lee SH; Moon SJ; Lee JA; Lee EJ; Kim EK; Park JS; Lee J; Min JK; Kim SJ; Park SH; Cho ML
Sci Rep; 2016 Nov; 6():35933. PubMed ID: 27804999
[TBL] [Abstract][Full Text] [Related]
4. RAGE-dependent signaling in microglia contributes to neuroinflammation, Abeta accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease.
Fang F; Lue LF; Yan S; Xu H; Luddy JS; Chen D; Walker DG; Stern DM; Yan S; Schmidt AM; Chen JX; Yan SS
FASEB J; 2010 Apr; 24(4):1043-55. PubMed ID: 19906677
[TBL] [Abstract][Full Text] [Related]
5. Effect of growth differentiation factor-15 secreted by human umbilical cord blood-derived mesenchymal stem cells on amyloid beta levels in in vitro and in vivo models of Alzheimer's disease.
Kim DH; Lee D; Lim H; Choi SJ; Oh W; Yang YS; Chang JH; Jeon HB
Biochem Biophys Res Commun; 2018 Oct; 504(4):933-940. PubMed ID: 30224067
[TBL] [Abstract][Full Text] [Related]
6. AGE-RAGE stress: a changing landscape in pathology and treatment of Alzheimer's disease.
Prasad K
Mol Cell Biochem; 2019 Sep; 459(1-2):95-112. PubMed ID: 31079281
[TBL] [Abstract][Full Text] [Related]
7. RAGE regulates BACE1 and Abeta generation via NFAT1 activation in Alzheimer's disease animal model.
Cho HJ; Son SM; Jin SM; Hong HS; Shin DH; Kim SJ; Huh K; Mook-Jung I
FASEB J; 2009 Aug; 23(8):2639-49. PubMed ID: 19332646
[TBL] [Abstract][Full Text] [Related]
8. Preventing activation of receptor for advanced glycation endproducts in Alzheimer's disease.
Lue LF; Yan SD; Stern DM; Walker DG
Curr Drug Targets CNS Neurol Disord; 2005 Jun; 4(3):249-66. PubMed ID: 15975028
[TBL] [Abstract][Full Text] [Related]
9. Thrombospondin-1 secreted by human umbilical cord blood-derived mesenchymal stem cells rescues neurons from synaptic dysfunction in Alzheimer's disease model.
Kim DH; Lim H; Lee D; Choi SJ; Oh W; Yang YS; Oh JS; Hwang HH; Jeon HB
Sci Rep; 2018 Jan; 8(1):354. PubMed ID: 29321508
[TBL] [Abstract][Full Text] [Related]
10. G82S polymorphism of receptor for advanced glycation end products gene and serum soluble RAGE levels in mild cognitive impairment and dementia of Alzheimer's type patients in Turkish population.
Ataç ZS; Alaylıoğlu M; Dursun E; Gezen-Ak D; Yılmazer S; Gürvit H
J Clin Neurosci; 2019 Jan; 59():197-201. PubMed ID: 30389362
[TBL] [Abstract][Full Text] [Related]
11. In vitro validation of effects of BDNF-expressing mesenchymal stem cells on neurodegeneration in primary cultured neurons of APP/PS1 mice.
Song MS; Learman CR; Ahn KC; Baker GB; Kippe J; Field EM; Dunbar GL
Neuroscience; 2015 Oct; 307():37-50. PubMed ID: 26297896
[TBL] [Abstract][Full Text] [Related]
12. An aqueous orally active vaccine targeted against a RAGE/AB complex as a novel therapeutic for Alzheimer's disease.
Webster SJ; Mruthinti S; Hill WD; Buccafusco JJ; Terry AV
Neuromolecular Med; 2012 Jun; 14(2):119-30. PubMed ID: 22415896
[TBL] [Abstract][Full Text] [Related]
13. Targeted inhibition of RAGE reduces amyloid-β influx across the blood-brain barrier and improves cognitive deficits in db/db mice.
Wang H; Chen F; Du YF; Long Y; Reed MN; Hu M; Suppiramaniam V; Hong H; Tang SS
Neuropharmacology; 2018 Mar; 131():143-153. PubMed ID: 29248482
[TBL] [Abstract][Full Text] [Related]
14. Effect of Linguizhugan decoction on neuroinflammation and expression disorder of the amyloid β‑related transporters RAGE and LRP‑1 in a rat model of Alzheimer's disease.
Hu Q; Yu B; Chen Q; Wang Y; Ling Y; Sun S; Shi Y; Zhou C
Mol Med Rep; 2018 Jan; 17(1):827-834. PubMed ID: 29115637
[TBL] [Abstract][Full Text] [Related]
15. Aβ1-42 reduces P-glycoprotein in the blood-brain barrier through RAGE-NF-κB signaling.
Park R; Kook SY; Park JC; Mook-Jung I
Cell Death Dis; 2014 Jun; 5(6):e1299. PubMed ID: 24967961
[TBL] [Abstract][Full Text] [Related]
16. Aβ
Chan Y; Chen W; Wan W; Chen Y; Li Y; Zhang C
Exp Cell Res; 2018 Aug; 369(2):266-274. PubMed ID: 29856989
[TBL] [Abstract][Full Text] [Related]
17. Effect of High Cholesterol Regulation of LRP1 and RAGE on Aβ Transport Across the Blood-Brain Barrier in Alzheimer's Disease.
Zhou R; Chen LL; Yang H; Li L; Liu J; Chen L; Hong WJ; Wang CG; Ma JJ; Huang J; Zhou XF; Liu D; Zhou HD
Curr Alzheimer Res; 2021; 18(5):428-442. PubMed ID: 34488598
[TBL] [Abstract][Full Text] [Related]
18. A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease.
Deane R; Singh I; Sagare AP; Bell RD; Ross NT; LaRue B; Love R; Perry S; Paquette N; Deane RJ; Thiyagarajan M; Zarcone T; Fritz G; Friedman AE; Miller BL; Zlokovic BV
J Clin Invest; 2012 Apr; 122(4):1377-92. PubMed ID: 22406537
[TBL] [Abstract][Full Text] [Related]
19. RAGE: a potential target for Abeta-mediated cellular perturbation in Alzheimer's disease.
Chen X; Walker DG; Schmidt AM; Arancio O; Lue LF; Yan SD
Curr Mol Med; 2007 Dec; 7(8):735-42. PubMed ID: 18331231
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow-derived mesenchymal stem cells contribute to the reduction of amyloid-β deposits and the improvement of synaptic transmission in a mouse model of pre-dementia Alzheimer's disease.
Bae JS; Jin HK; Lee JK; Richardson JC; Carter JE
Curr Alzheimer Res; 2013 Jun; 10(5):524-31. PubMed ID: 23036020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
